Semaglutide: A clear star in GLP-1 trials Semaglutide trials are surging, too, representing more than one-third of GLP-1 trials (as shown above)
Primary care providers should be referring patients to dietitians, said Rachel Naar, a registered dietitian nutritionist who works with eating disorder patients
Do the ratios look correct to you
GLP-1 medications, on the other hand, may be better suited for: Patients who are medication sensitive and prefer a single-pathway approach Those who want a slower, steadier progression with gradual appetite changes Individuals primarily struggling with appetite control rather than metabolic dysfunction For these patients, GLP-1 therapy may provide sufficient appetite regulation without the need for more aggressive metabolic intervention
We recommend receiving glutathione injections 1 to 3 times per week for optimal results
Athletes often need more structured fuelling plans with smaller, more frequent carbohydrate doses and scheduled hydration because hunger and thirst cues become less reliable